2009
Epidemiology and Intervention Trials
Mayne S, Wright M, Cartmel B. Epidemiology and Intervention Trials. Carotenoids 2009, 191-210. DOI: 10.1007/978-3-7643-7501-0_10.ChaptersChronic diseasesDeterminants of diseaseIntervention trialsHeart diseaseCarotenoid statusMacular degenerationCarotenoid intakeDisease endpointsEpidemiological researchDiseaseOxidative stressHealth effectsAntioxidant functionEpidemiologyRiskEtiologyCancerCataractDegenerationHuman populationIntakeTrialsEndpoint
1999
Plasma Lycopene Concentrations in Humans Are Determined by Lycopene Intake, Plasma Cholesterol Concentrations and Selected Demographic Factors 1 , 2
Mayne S, Cartmel B, Silva F, Kim C, Fallon B, Briskin K, Zheng T, Baum M, Shor-Posner G, Goodwin W. Plasma Lycopene Concentrations in Humans Are Determined by Lycopene Intake, Plasma Cholesterol Concentrations and Selected Demographic Factors 1 , 2. Journal Of Nutrition 1999, 129: 849-854. PMID: 10203560, DOI: 10.1093/jn/129.4.849.Peer-Reviewed Original ResearchConceptsPlasma lycopene levelsPlasma lycopene concentrationsPlasma cholesterolLycopene levelsPlasma lycopeneLycopene intakeLycopene concentrationHigher plasma lycopene concentrationsNonwhite race/ethnicityDietary lycopene intakeCancer Prevention TrialMarital statusLow dietary intakeLower plasma cholesterolPlasma cholesterol concentrationLow plasma concentrationsLess vitamin CRace/ethnicityPrevention trialsDietary lycopeneTriglyceride levelsUnivariate analysisDietary intakeChronic diseasesPlasma concentrations